TGATG vector: a new expression system for cloned foreign genes in Escherichia coli cells. 1990

S V Mashko, and V P Veiko, and A L Lapidus, and M I Lebedeva, and A V Mochulsky, and I I Shechter, and M E Trukhan, and K I Ratmanova, and B A Rebentish, and V E Kaluzhsky
Institute of Genetics and Selection of Industrial Microorganisms, Moscow U.S.S.R.

A TGATG vector system was developed that allows for the construction of hybrid operons with partially overlapping genes, employing the effects of translational coupling to optimize expression of cloned cistrons in Escherichia coli. In this vector system (plasmid pPR-TGATG-1), the coding region of a foreign gene is attached to the ATG codon situated on the vector, to form the hybrid operon transcribed from the phage lambda PR promoter. The cloned gene is the distal cistron of this hybrid operon ('overlappon'). The efficiently translated cro'-cat'-'trpE hybrid cistron is proximal to the promoter. The coding region of this artificial fused cistron [the length of the corresponding open reading frame is about 120 amino acids (aa)] includes the following: the N-terminal portions of phage lambda Cro protein (20 aa), the CAT protein of E. coli (72 aa) and 3' C-terminal codons of the E. coli trpE gene product. At the 3'-end of the cro'-cat'-'trpE fused cistron there is a region for efficient translation reinitiation: a Shine-Dalgarno sequence of the E. coli trpD gene and the overlapping stop and start codons (TGATG). In this sequence, the last G is the first nucleotide of the unique SacI-recognition site (GAGCT decreases C) and so integration of the structural part of the foreign gene into the vector plasmid may be performed using blunt-end DNA linking after the treatment of pPR-TGATG-1 with SacI and E. coli DNA polymerase I or its Klenow fragment.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009693 Nucleic Acid Hybridization Widely used technique which exploits the ability of complementary sequences in single-stranded DNAs or RNAs to pair with each other to form a double helix. Hybridization can take place between two complimentary DNA sequences, between a single-stranded DNA and a complementary RNA, or between two RNA sequences. The technique is used to detect and isolate specific sequences, measure homology, or define other characteristics of one or both strands. (Kendrew, Encyclopedia of Molecular Biology, 1994, p503) Genomic Hybridization,Acid Hybridization, Nucleic,Acid Hybridizations, Nucleic,Genomic Hybridizations,Hybridization, Genomic,Hybridization, Nucleic Acid,Hybridizations, Genomic,Hybridizations, Nucleic Acid,Nucleic Acid Hybridizations
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D004274 DNA, Recombinant Biologically active DNA which has been formed by the in vitro joining of segments of DNA from different sources. It includes the recombination joint or edge of a heteroduplex region where two recombining DNA molecules are connected. Genes, Spliced,Recombinant DNA,Spliced Gene,Recombinant DNA Research,Recombination Joint,DNA Research, Recombinant,Gene, Spliced,Joint, Recombination,Research, Recombinant DNA,Spliced Genes
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D005798 Genes, Bacterial The functional hereditary units of BACTERIA. Bacterial Gene,Bacterial Genes,Gene, Bacterial
D005822 Genetic Vectors DNA molecules capable of autonomous replication within a host cell and into which other DNA sequences can be inserted and thus amplified. Many are derived from PLASMIDS; BACTERIOPHAGES; or VIRUSES. They are used for transporting foreign genes into recipient cells. Genetic vectors possess a functional replicator site and contain GENETIC MARKERS to facilitate their selective recognition. Cloning Vectors,Shuttle Vectors,Vectors, Genetic,Cloning Vector,Genetic Vector,Shuttle Vector,Vector, Cloning,Vector, Genetic,Vector, Shuttle,Vectors, Cloning,Vectors, Shuttle
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D015183 Restriction Mapping Use of restriction endonucleases to analyze and generate a physical map of genomes, genes, or other segments of DNA. Endonuclease Mapping, Restriction,Enzyme Mapping, Restriction,Site Mapping, Restriction,Analysis, Restriction Enzyme,Enzyme Analysis, Restriction,Restriction Enzyme Analysis,Analyses, Restriction Enzyme,Endonuclease Mappings, Restriction,Enzyme Analyses, Restriction,Enzyme Mappings, Restriction,Mapping, Restriction,Mapping, Restriction Endonuclease,Mapping, Restriction Enzyme,Mapping, Restriction Site,Mappings, Restriction,Mappings, Restriction Endonuclease,Mappings, Restriction Enzyme,Mappings, Restriction Site,Restriction Endonuclease Mapping,Restriction Endonuclease Mappings,Restriction Enzyme Analyses,Restriction Enzyme Mapping,Restriction Enzyme Mappings,Restriction Mappings,Restriction Site Mapping,Restriction Site Mappings,Site Mappings, Restriction
D015964 Gene Expression Regulation, Bacterial Any of the processes by which cytoplasmic or intercellular factors influence the differential control of gene action in bacteria. Bacterial Gene Expression Regulation,Regulation of Gene Expression, Bacterial,Regulation, Gene Expression, Bacterial

Related Publications

S V Mashko, and V P Veiko, and A L Lapidus, and M I Lebedeva, and A V Mochulsky, and I I Shechter, and M E Trukhan, and K I Ratmanova, and B A Rebentish, and V E Kaluzhsky
March 1990, Journal of biotechnology,
S V Mashko, and V P Veiko, and A L Lapidus, and M I Lebedeva, and A V Mochulsky, and I I Shechter, and M E Trukhan, and K I Ratmanova, and B A Rebentish, and V E Kaluzhsky
October 1996, Gene,
S V Mashko, and V P Veiko, and A L Lapidus, and M I Lebedeva, and A V Mochulsky, and I I Shechter, and M E Trukhan, and K I Ratmanova, and B A Rebentish, and V E Kaluzhsky
January 1990, Methods in enzymology,
S V Mashko, and V P Veiko, and A L Lapidus, and M I Lebedeva, and A V Mochulsky, and I I Shechter, and M E Trukhan, and K I Ratmanova, and B A Rebentish, and V E Kaluzhsky
June 1995, Analytical biochemistry,
S V Mashko, and V P Veiko, and A L Lapidus, and M I Lebedeva, and A V Mochulsky, and I I Shechter, and M E Trukhan, and K I Ratmanova, and B A Rebentish, and V E Kaluzhsky
June 2009, Biotechnology letters,
S V Mashko, and V P Veiko, and A L Lapidus, and M I Lebedeva, and A V Mochulsky, and I I Shechter, and M E Trukhan, and K I Ratmanova, and B A Rebentish, and V E Kaluzhsky
May 1994, BioTechniques,
S V Mashko, and V P Veiko, and A L Lapidus, and M I Lebedeva, and A V Mochulsky, and I I Shechter, and M E Trukhan, and K I Ratmanova, and B A Rebentish, and V E Kaluzhsky
December 1987, DNA (Mary Ann Liebert, Inc.),
S V Mashko, and V P Veiko, and A L Lapidus, and M I Lebedeva, and A V Mochulsky, and I I Shechter, and M E Trukhan, and K I Ratmanova, and B A Rebentish, and V E Kaluzhsky
January 1985, Gene,
S V Mashko, and V P Veiko, and A L Lapidus, and M I Lebedeva, and A V Mochulsky, and I I Shechter, and M E Trukhan, and K I Ratmanova, and B A Rebentish, and V E Kaluzhsky
January 1983, DNA (Mary Ann Liebert, Inc.),
S V Mashko, and V P Veiko, and A L Lapidus, and M I Lebedeva, and A V Mochulsky, and I I Shechter, and M E Trukhan, and K I Ratmanova, and B A Rebentish, and V E Kaluzhsky
April 1995, BioTechniques,
Copied contents to your clipboard!